Abstract
ABSTRACT
Traditional in‐person consultations for genetic services create access barriers. We hypothesized that the Genetics Adviser platform—a web‐based digital platform delivering clinical genomic services—could reduce these barriers. Focusing on pretest education and counseling, we tested a pilot version of the platform in medical genetics and pediatric endocrinology group practices. The multimethod design consisted of quantitative patient and caregiver surveys, Google Analytics data, and qualitative healthcare provider interviews. Surveys included validated measures of acceptability and empowerment. Transcribed interviews were thematically coded and analyzed using NVivo. Of the 102 patients and caregivers targeted for this study, 85/102 (83%) accessed the platform, 71/102 (70%) proceeded beyond the landing page, and 60/102 (59%) completed the post‐module survey. Users expressed high confidence in genetic understanding and empowerment (Genomics Outcome Scale [GOS]: 77/100), and providers noted potential benefits and highlighted technological and content‐related limitations. Further research is needed to validate effectiveness across diverse populations and to evaluate long‐term impacts on patient outcomes and healthcare efficiency.